DELCATH SYSTEMS
Delcath Systems and its proprietary targeted drug delivery system are at the forefront of the regional treatment of cancer. The Company's technology, known as Percutaneous Hepatic Perfusion (PHP), allows physicians to deliver significantly higher doses of anti-cancer drugs to the site of disease without exposing the patient's entire body to those same potent levels of drug. Initial clinical results from studies treating cancer in the liver confirm that delivering more drug to the tumor site, and less to the other regions of the body, enhances tumor shrinkage with improved quality of life over systemic cancer therapies. PHP is currently undergoing testing in Phase III and Phase II clinical trials for a variety of cancers of the liver.
DELCATH SYSTEMS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
1987-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.delcath.com
Total Employee:
11+
Status:
Active
Contact:
2124892102
Email Addresses:
[email protected]
Total Funding:
143.4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon WordPress Apache Sitelinks Search Box Microsoft Exchange Online Organization Schema
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Atlas Venture
Atlas Venture creates and invests in biotech startup companies with seed and early stage venture investments.
EpiVax
EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Current Employees Featured
Stock Details
Investors List
Avenue Capital Group
Avenue Capital Group investment in Post-IPO Debt - Delcath Systems
Silicon Valley Bank
Silicon Valley Bank investment in Post-IPO Debt - Delcath Systems
Official Site Inspections
http://www.delcath.com Semrush global rank: 7.75 M Semrush visits lastest month: 437
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Delcath Systems"
About Us - Delcath
Mr. Muir joins Delcath Systems with 20 years of sales and marketing experience in the biotherapeutics and medical technology industries. Before joining Delcath, Mr. Muir was …See details»
Delcath Systems - Wikipedia
Delcath Systems, Inc. (NASDAQ: DCTH) is a publicly traded specialty pharmaceutical and medical device company, [1] that develops percutaneous perfusion technologies for the …See details»
DELCATHSYSTEMS.COM
Delcath Systems, Inc. at 2nd Annual Disruptive Growth & Healthcare Conference February 15, 2017. See All Investor Events and Webcasts. Featured News. Latest News. September 22, …See details»
Delcath Systems - Crunchbase Company Profile
Delcath Systems is an interventional oncology company that focuses on the treatment of metastatic liver cancer. Its proprietary product Melphalan …See details»
Committee Composition - Delcath Systems, Inc.
The Investor Relations website contains information about Delcath Systems, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
Delcath Systems - Leadership Team - The Org
The Leadership Team at Delcath Systems oversees strategic direction and operational execution to drive innovation in cancer treatment. Comprising senior executives from finance, operations, …See details»
Delcath Systems - The Org
Delcath Systems and its proprietary targeted drug delivery system are at the forefront of the regional treatment of cancer. Industries. Biotechnology, Health Care + 1. Headquarters.See details»
Delcath Systems Org Chart + Executive Team - The …
The organizational chart of Delcath Systems displays its 13 main executives including Gerard Michel, Martha Rook and David Hoffman. Toggle navigation The Official Board. Search. Search. Search by segment. ... you don't own enough …See details»
Delcath Systems, Inc. Company Profile - Dun & Bradstreet
Doing Business As: Delcath Company Description: A cancer-stricken liver might be a lonely little organ, thanks to Delcath Systems. The company's technology allows blood infused with …See details»
Delcath Systems to Host First Quarter 2025 Earnings Call
6 days ago Delcath Systems, Inc., an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced today it will host a conference call …See details»
Delcath Systems - Clinical Operations and Research - The Org
The Clinical Operations and Research team at Delcath Systems is responsible for designing, implementing, and overseeing clinical trials to evaluate the safety and efficacy of their …See details»
Delcath Systems Company Profile - Office Locations, Competitors …
Delcath Systems has 4 employees across 3 locations and $2.07 m in annual revenue in FY 2023. See insights on Delcath Systems including office locations, competitors, revenue, financials, …See details»
Delcath Systems Inc Company Profile - Overview - GlobalData
Delcath Systems Inc (Delcath) is a medical technology company with a primary focus on oncology. The company's main activities involve the development and marketing of proprietary …See details»
Delcath Systems Announces FDA Clearance of IND Application for …
3 days ago QUEENSBURY, N.Y., April 28, 2025--Delcath Systems, Inc. (NASDAQ: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver …See details»
Delcath - Products, Competitors, Financials, Employees, …
Delcath Systems, Inc. is a specialty pharmaceutical and medical device company focused on the treatment of primary and metastatic liver cancers. The company offers a proprietary product, …See details»
Delcath Systems Reports Fourth Quarter and Full Year 2024 …
Dec 31, 2024 Conference Call Today at 8:30 a.m. Eastern Time. QUEENSBURY, N.Y.--(BUSINESS WIRE)--Mar. 6, 2025-- Delcath Systems, Inc. (Nasdaq: DCTH) (“Delcath” or the …See details»
Delcath Systems - Overview, News & Similar companies - ZoomInfo
Mar 18, 2024 Delcath Systems Announces Poster Presentation at the 2024 ESMO Congress NEW YORK--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH) (the “Company” or …See details»
Delcath Systems, Inc. - PRISM MarketView
Delcath Systems, Inc. is a specialty pharmaceutical and medical device company focused on the treatment of primary and metastatic liver cancers. Our proprietary product—Melphalan …See details»
Delcath Systems Announces FDA Clearance of IND ... - Morningstar
3 days ago Delcath Systems, Inc. is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. The company's proprietary products, …See details»
Working At Delcath Systems: Company Overview and Culture
Mar 14, 2024 Founded in 1987, Delcath Systems is an established company that loves to hire graduates from Villanova University, with 5.6% of its employees having attended Villanova …See details»